MR Imaging during Intracavitary Brachytherapy of Vaginal and Cervical Cancer: Preliminary Results

Anne A. Tardivon, Karen Kinkel, Eric Lartigau, Jacques Masselot, Alain P. Gerbaulet, Daniel Vanel

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Intracavitary brachytherapy is an effective treatment for gynecologic cancers. Twelve magnetic resonance (MR) imaging studies were performed during intracavitary brachytherapy (10 initial studies and two during repeat brachytherapy) in 10 patients with clear cell adenocarcinoma (n = 9) or epithelioma (n = 1). Fifty percent of the vaginal lesions did not demonstrate high signal intensity on T2-weighted images. Individually tailored molded applicators allowed easy detection of abnormal vaginal parietal thickening on T1-weighted images: Results in seven cases were concordant with results of clinical examination, and there were no false-negative results. MR imaging was useful in controlling the relationships between the tumor and the applicator and facilitated treatment planning, since the radiation dose to the tumor volume and adjacent critical organs could be calculated accurately. Limitations of MR imaging were underestimation of superficial vaginal tumors and the inability to differentiate between tumor and inflammation after recent surgery or repeat intracavitary brachytherapy. MR imaging during intracavitary brachytherapy appears to be a useful adjunct to clinical examination.

Original languageEnglish
Pages (from-to)1363-1370
Number of pages8
JournalRadiographics
Volume16
Issue number6
Publication statusPublished - 1996

Fingerprint

Vaginal Neoplasms
Brachytherapy
Uterine Cervical Neoplasms
Magnetic Resonance Imaging
Neoplasms
Clear Cell Adenocarcinoma
Tumor Burden
Reoperation
Radiation
Inflammation
Carcinoma
Therapeutics

Keywords

  • Uterine neoplasms, staging, 854.324
  • Uterine neoplasms, therapeutic radiology, 854.1299, 854.452
  • Vagina, neoplasms, 855.324
  • Vagina, therapeutic radiology, 855.1299, 855.452

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Tardivon, A. A., Kinkel, K., Lartigau, E., Masselot, J., Gerbaulet, A. P., & Vanel, D. (1996). MR Imaging during Intracavitary Brachytherapy of Vaginal and Cervical Cancer: Preliminary Results. Radiographics, 16(6), 1363-1370.

MR Imaging during Intracavitary Brachytherapy of Vaginal and Cervical Cancer : Preliminary Results. / Tardivon, Anne A.; Kinkel, Karen; Lartigau, Eric; Masselot, Jacques; Gerbaulet, Alain P.; Vanel, Daniel.

In: Radiographics, Vol. 16, No. 6, 1996, p. 1363-1370.

Research output: Contribution to journalArticle

Tardivon, AA, Kinkel, K, Lartigau, E, Masselot, J, Gerbaulet, AP & Vanel, D 1996, 'MR Imaging during Intracavitary Brachytherapy of Vaginal and Cervical Cancer: Preliminary Results', Radiographics, vol. 16, no. 6, pp. 1363-1370.
Tardivon AA, Kinkel K, Lartigau E, Masselot J, Gerbaulet AP, Vanel D. MR Imaging during Intracavitary Brachytherapy of Vaginal and Cervical Cancer: Preliminary Results. Radiographics. 1996;16(6):1363-1370.
Tardivon, Anne A. ; Kinkel, Karen ; Lartigau, Eric ; Masselot, Jacques ; Gerbaulet, Alain P. ; Vanel, Daniel. / MR Imaging during Intracavitary Brachytherapy of Vaginal and Cervical Cancer : Preliminary Results. In: Radiographics. 1996 ; Vol. 16, No. 6. pp. 1363-1370.
@article{74f8c22a04cd473584d72b57924a91c6,
title = "MR Imaging during Intracavitary Brachytherapy of Vaginal and Cervical Cancer: Preliminary Results",
abstract = "Intracavitary brachytherapy is an effective treatment for gynecologic cancers. Twelve magnetic resonance (MR) imaging studies were performed during intracavitary brachytherapy (10 initial studies and two during repeat brachytherapy) in 10 patients with clear cell adenocarcinoma (n = 9) or epithelioma (n = 1). Fifty percent of the vaginal lesions did not demonstrate high signal intensity on T2-weighted images. Individually tailored molded applicators allowed easy detection of abnormal vaginal parietal thickening on T1-weighted images: Results in seven cases were concordant with results of clinical examination, and there were no false-negative results. MR imaging was useful in controlling the relationships between the tumor and the applicator and facilitated treatment planning, since the radiation dose to the tumor volume and adjacent critical organs could be calculated accurately. Limitations of MR imaging were underestimation of superficial vaginal tumors and the inability to differentiate between tumor and inflammation after recent surgery or repeat intracavitary brachytherapy. MR imaging during intracavitary brachytherapy appears to be a useful adjunct to clinical examination.",
keywords = "Uterine neoplasms, staging, 854.324, Uterine neoplasms, therapeutic radiology, 854.1299, 854.452, Vagina, neoplasms, 855.324, Vagina, therapeutic radiology, 855.1299, 855.452",
author = "Tardivon, {Anne A.} and Karen Kinkel and Eric Lartigau and Jacques Masselot and Gerbaulet, {Alain P.} and Daniel Vanel",
year = "1996",
language = "English",
volume = "16",
pages = "1363--1370",
journal = "Radiographics",
issn = "0271-5333",
publisher = "Radiological Society of North America Inc.",
number = "6",

}

TY - JOUR

T1 - MR Imaging during Intracavitary Brachytherapy of Vaginal and Cervical Cancer

T2 - Preliminary Results

AU - Tardivon, Anne A.

AU - Kinkel, Karen

AU - Lartigau, Eric

AU - Masselot, Jacques

AU - Gerbaulet, Alain P.

AU - Vanel, Daniel

PY - 1996

Y1 - 1996

N2 - Intracavitary brachytherapy is an effective treatment for gynecologic cancers. Twelve magnetic resonance (MR) imaging studies were performed during intracavitary brachytherapy (10 initial studies and two during repeat brachytherapy) in 10 patients with clear cell adenocarcinoma (n = 9) or epithelioma (n = 1). Fifty percent of the vaginal lesions did not demonstrate high signal intensity on T2-weighted images. Individually tailored molded applicators allowed easy detection of abnormal vaginal parietal thickening on T1-weighted images: Results in seven cases were concordant with results of clinical examination, and there were no false-negative results. MR imaging was useful in controlling the relationships between the tumor and the applicator and facilitated treatment planning, since the radiation dose to the tumor volume and adjacent critical organs could be calculated accurately. Limitations of MR imaging were underestimation of superficial vaginal tumors and the inability to differentiate between tumor and inflammation after recent surgery or repeat intracavitary brachytherapy. MR imaging during intracavitary brachytherapy appears to be a useful adjunct to clinical examination.

AB - Intracavitary brachytherapy is an effective treatment for gynecologic cancers. Twelve magnetic resonance (MR) imaging studies were performed during intracavitary brachytherapy (10 initial studies and two during repeat brachytherapy) in 10 patients with clear cell adenocarcinoma (n = 9) or epithelioma (n = 1). Fifty percent of the vaginal lesions did not demonstrate high signal intensity on T2-weighted images. Individually tailored molded applicators allowed easy detection of abnormal vaginal parietal thickening on T1-weighted images: Results in seven cases were concordant with results of clinical examination, and there were no false-negative results. MR imaging was useful in controlling the relationships between the tumor and the applicator and facilitated treatment planning, since the radiation dose to the tumor volume and adjacent critical organs could be calculated accurately. Limitations of MR imaging were underestimation of superficial vaginal tumors and the inability to differentiate between tumor and inflammation after recent surgery or repeat intracavitary brachytherapy. MR imaging during intracavitary brachytherapy appears to be a useful adjunct to clinical examination.

KW - Uterine neoplasms, staging, 854.324

KW - Uterine neoplasms, therapeutic radiology, 854.1299, 854.452

KW - Vagina, neoplasms, 855.324

KW - Vagina, therapeutic radiology, 855.1299, 855.452

UR - http://www.scopus.com/inward/record.url?scp=0030278391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030278391&partnerID=8YFLogxK

M3 - Article

C2 - 8946541

AN - SCOPUS:0030278391

VL - 16

SP - 1363

EP - 1370

JO - Radiographics

JF - Radiographics

SN - 0271-5333

IS - 6

ER -